| Name | Title | Contact Details |
|---|
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Pharos Life is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Max Neeman International is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
"At EMD Millipore, one of the top three investors in R&D in the Life Science Tools industry, we develop cutting-edge technologies and services for bioscience research and biopharmaceutical manufacturing. Innovation drives everything we do. And it’s reinforced by our collaborative culture, pioneering spirit and unwavering focus on the world’s most challenging human health issues. EMD Millipore, known outside North America as Merck Millipore, is part of the Merck Group, a global company with 40,000 employees in more than 60 countries. EMD Millipore is a division of Merck KGaA, Darmstadt, Germany."
Center for Bio-Medical Communication is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.